The world's first scientific journal is still publishing. And it's still one of the most respected venues in biology.
That sentence still surprises people. Still, same society. But Philosophical Transactions of the Royal Society B* — Phil Trans B to the people who read it — has been running continuously since 1665. They assume the oldest journals folded, or got absorbed, or turned into something unrecognizable. Same title. Same mission: publish the best biological science, rigorously reviewed, for the global community.
It predates the word "biology" by over a century. It published Darwin. It published Newton. It published the first paper on photosynthesis, the first description of a virus, the first evidence of jumping genes. And this morning, it published a theme issue on microbiome engineering and another on the evolutionary dynamics of cancer.
If you work in the life sciences, you've cited it. If you're early career, you've probably dreamed of publishing in it. But most people don't actually know how it works, what makes it different, or why it still matters in a world of preprints and mega-journals.
Let's fix that.
What Is Philosophical Transactions B
Phil Trans B is the Royal Society's flagship biological sciences journal. On the flip side, the "B" stands for biological sciences — its sister journal, Philosophical Transactions A*, covers physical sciences and mathematics. They split in 1887, after more than two centuries as a single publication covering all of natural philosophy.
The name throws people. "Philosophical Transactions" sounds like a philosophy journal. It's not. And in the 17th century, "natural philosophy" was the term for what we now call science. Now, the "transactions" part referred to the transactions — the proceedings, the business — of the Royal Society. The journal was literally the society's newsletter, printed and distributed to fellows.
Today it's a monthly journal with an impact factor consistently above 6, fully hybrid open access, publishing both regular issues and themed collections. But the DNA hasn't changed: it's still the Royal Society's journal, run by scientists for scientists, with editorial decisions made by active researchers rather than professional editors.
The Theme Issue Model
This is the thing most people miss. A huge fraction of its output — often 50% or more — comes in theme issues. Phil Trans B doesn't just publish papers as they arrive. These are curated collections of 10–20 papers around a single topic, guest-edited by leading experts in that field.
Think of them as mini-textbooks that happen to be peer-reviewed primary literature. A theme issue on "The evolution of social behaviour" might include theoretical models, field studies, genomic analyses, and a synthesis paper — all commissioned to work together. You don't just get a paper; you get a snapshot of an entire subfield at that moment.
Guest editors propose topics. And the editorial board approves. Papers are invited and accepted from open calls. Every paper goes through full peer review. The result is something you can hand to a grad student and say "read this issue — you'll know the state of the art.
Why It Matters / Why People Care
Prestige is the obvious answer. But prestige is a lagging indicator. The real question is: what does this journal do that others don't?
It Publishes Synthesis, Not Just Novelty
Most high-impact journals chase novelty. And new mechanism. New species. New method. Phil Trans B publishes those too — but it also publishes synthesis papers that connect dots across subfields. The kind of paper that doesn't have a single new data point but changes how you think about a problem.
I've seen reviewers at other journals reject synthesis papers as "not novel enough." At Phil Trans B, that's often a strength. The editorial philosophy explicitly values perspective pieces, reviews, and synthetic frameworks — especially in theme issues.
It's Society-Owned, Not Profit-Driven
The Royal Society is a fellowship of scientists. But the journal's surplus funds go back into science: grants, fellowships, policy work, education. There's no shareholder pressure to increase article volume, lower acceptance rates for prestige signaling, or push APCs higher than the market bears.
That independence shows in decisions. When the open access mandate wave hit, Phil Trans B didn't flip to gold OA overnight. Now, it moved deliberately, kept hybrid options, negotiated transformative agreements, and protected authors without funders. It's one of the few top-tier journals where the editorial board would actually push back if the publisher made a decision that harmed science.
The Archive Is a Time Machine
Because it's been continuous since 1665, the archive is a living history of biology. You can trace the discovery of oxygen, the formulation of cell theory, the first genetic maps, the birth of molecular biology — all in the same journal, same format, same society.
The Royal Society digitized the entire run. It's free to access. You can read Hooke's micrographia observations, Darwin's geological notes from the Beagle, Hodgkin and Huxley's action potential papers, the first CRISPR papers — all in one place, with modern metadata.
That matters for more than nostalgia. It means the journal has institutional memory. Editors know the history of their field because it's in the journal*.
How It Works
Editorial Structure
No professional editors. The Editor-in-Chief is a practicing scientist — currently Professor Jane Hillston (as of my knowledge cutoff), a computational biologist. She's supported by Associate Editors, all active researchers, each handling a portfolio of subject areas.
When a paper arrives, an Associate Editor evaluates scope and quality. Day to day, the AE makes the decision. If it clears that bar, they send it to reviewers. The Editor-in-Chief only gets involved on appeals or borderline cases.
This means your paper is judged by someone who does* your kind of science. Not a generalist editor who last pipetted in 2004.
The Review Process
Standard single-blind peer review. Reviewers are chosen for expertise, not just availability. That said, the journal publishes reviewer reports alongside accepted papers (opt-in for authors, but most say yes). You can see exactly what the reviewers asked for and how the authors responded.
If you found this helpful, you might also enjoy phrs 564. drug delivery and nanomedicine ii pdf or how to treat fire ant stings.
This transparency changes behavior. Which means reviewers write better reports. Authors revise more thoroughly. Readers get context.
Timeline: first decision typically 4–6 weeks. Worth adding: acceptance to online publication: 2–3 weeks. Theme issue papers follow a coordinated schedule — they publish together.
Article Types
- Research articles — standard primary research
- Reviews — invited or proposed, comprehensive syntheses
- Perspective pieces — opinionated but evidence-based, often forward-looking
- Theme issue introductions — the guest editors' framing essay
- Comments and replies — post-publication discourse (rare but happens)
Word limits are generous. No artificial constraints to fit a print layout — there is no print layout anymore.
Open Access Options
Fully hybrid. You can publish:
- Gold OA — pay APC (~£2,500 / $3,200), CC BY license, immediate open access
- Green OA — publish subscription, deposit accepted manuscript in repository after 12-month embargo
- Transformative agreements — if your institution has a read-and-publish deal with the Royal Society, OA fees are covered
So, the Royal Society was early to transformative agreements and has deals with Jisc (UK), consortia in Germany, Sweden, Norway, Finland, and others. Check your library.
Common Mistakes / What Most People Get Wrong
"It's Only for Est
"It's Only for Established Scientists"
This is perhaps the most persistent myth. On the flip side, while the journal does publish work from senior figures, it actively seeks high-quality contributions from early-career researchers. The editorial board includes many associate editors who were themselves early-career when they first published in the journal. What matters is the rigor and significance of the work, not the reputation of the lab.
"The Process Is Too Slow"
With first decisions typically arriving within 4–6 weeks, the journal actually moves faster than many traditional subscription journals. The bottleneck isn't editorial inefficiency—it's the peer review process itself. The journal has implemented reviewer incentives and recognition systems to encourage timely feedback, but ultimately quality takes time.
"Theme Issues Are Less Rigorous"
Theme issues undergo the same peer review process as regular submissions. Practically speaking, the difference lies in curation, not standards. Guest editors may have broader latitude in topic selection, but each paper still faces scrutiny from the same associate editors and reviewers as standalone articles.
"Open Access Means Lower Quality"
The hybrid model allows authors to choose their preferred path without compromising editorial standards. Which means papers published under Gold OA undergo identical review processes to those behind the subscription paywall. The journal's impact factor and reputation remain consistent across both publication tracks.
Strategic Considerations
When to Submit
The journal favors papers that advance theoretical understanding or introduce novel methodological approaches. Practically speaking, if your work primarily reports empirical findings without broader conceptual implications, other venues might be more appropriate. That said, papers that bridge theory and application—especially those demonstrating practical utility of theoretical advances—are particularly welcome.
Maximizing Impact
Publishing in this venue offers unique visibility within the computational biology community. Even so, the journal's readership includes both theoreticians and experimentalists, creating opportunities for cross-disciplinary collaboration. Authors should consider how their theoretical contributions might translate to biological insights or computational tools.
Building Your Career
For early-career researchers, publishing in a venue with strong editorial connections can open doors to collaborations and speaking engagements. The journal regularly features emerging voices in the field, and associate editors often become future collaborators or mentors.
Looking Forward
As computational biology continues evolving toward more data-intensive and interdisciplinary research, journals must adapt accordingly. This publication model—with its emphasis on expert editorial oversight, transparent review processes, and flexible publishing options—positions it well for these changes.
The integration of artificial intelligence tools in manuscript handling and review processes is already beginning. Still, the core principle remains unchanged: connecting rigorous scientific work with readers who can best appreciate and build upon it.
Conclusion
This journal represents a thoughtful evolution of academic publishing—one that prioritizes scientific substance over commercial considerations. By maintaining editorial expertise within the research community, embracing transparency in peer review, and adapting to modern publishing needs, it serves as a model for how scholarly communication can better support the advancement of science.
For researchers seeking a venue that values deep scientific understanding and maintains connections to the field's intellectual heritage, this journal offers both opportunity and influence. Its continued success depends not just on attracting high-quality submissions, but on fostering the kind of scholarly dialogue that drives progress forward.
